Showing results (1461-1470 of 3,637) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|September 1, 2015
Insights into biology of luminal HER2 vs. enriched HER2 subtypes: Therapeutic implicationsNadia HarbeckBreast (Edinburgh, Scotland)|October 1, 2015
Dry eyes and AIs: If you don't ask you won't find outHolly Inglis, Frances M Boyle, Michael L Friedlander, et al.Breast (Edinburgh, Scotland)|October 1, 2015
Exploring information provision in reconstructive breast surgery: A qualitative studyShelley Potter, Nicola Mills, Simon Cawthorn, et al.Breast (Edinburgh, Scotland)|August 9, 2015
Clinical implications of the intrinsic molecular subtypes of breast cancerAleix Prat, Estela Pineda, Barbara Adamo, et al.Breast (Edinburgh, Scotland)|August 11, 2015
Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancerAju Mathew, Nancy E DavidsonBreast (Edinburgh, Scotland)|September 8, 2015
Neoadjuvant chemotherapy is not a contraindication for nipple sparing mastectomyStefano Santoro, Andrea Loreti, Francesco Cavaliere, et al.Breast (Edinburgh, Scotland)|August 17, 2015
The locoregional recurrence post-mastectomy for ductal carcinoma in situ: Incidence and risk factorsSahar Bannani, Sophie Rouquette, Cecile Bendavid-Athias, et al.Breast (Edinburgh, Scotland)|August 18, 2015
Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and BelgiumGertrude Luyeye Mvila, Donatien Batalansi, Marleen Praet, et al.Breast (Edinburgh, Scotland)|January 22, 2015
Understanding the factors that influence breast reconstruction decision making in Australian womenRon Barry Somogyi, Angela Webb, Nairy Baghdikian, et al.Breast (Edinburgh, Scotland)|December 7, 2014
Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment responseChristoph I Lee, Laura S Gold, Heidi D Nelson, et al.Pageof 364